Skip to main content
Presentation
Extracorpeal albumin dialysis with molecular adsorbent recirculating systems (MARS) and the effect on antimicrobial removal
Hepatology
  • Erika Aldag, Advocate Aurora Health
  • Lynne Fehrenbacher
  • Uvidelio Castillo
  • Ajay Sahajpal, Advocate Aurora Health
  • Vikraman Gunabushanam, Advocate Aurora Health
  • Fadi Hussein, Advocate Aurora Health
  • Manpreet Chadha, Advocate Aurora Health
  • David Kramer, Advocate Aurora Health
Affiliations

Aurora St. Luke's Medical Center (ASLMC)

Publication Date
1-1-2016
Presentation Notes
Poster presented at: Aurora Scientific Day; May 25, 2016; Milwaukee, WI.
Abstract

Conclusion: Our recommendations for empiric antimicrobial dosing in MARS patients achieved adequate concentrations for the drugs sampled in our small patient population. Due to the observational study design, the potential impact on antimicrobial pharmacokinetics was not evaluated. Our investigation is ongoing in order to evaluate additional antimicrobials and the impact of more prolonged MARS runs. Additional data will be shared at Aurora Scientific Day.

Document Type
Poster
Citation Information

Aldag E, Fehrenbacher L, Castillo U, Sahajpal AJ, Gunabushanam V, Hussein F, Chadha M, Kramer DJ. Extracorpeal albumin dialysis with molecular adsorbent recirculating system (MARS) and the effect on antimicrobial removal. Poster presented at: Aurora Scientific Day; May 25, 2016; Milwaukee, WI.